RIGEL PHARMACEUTICALS, INC. (RIGL) Capital expenditures 2016–2023
RIGEL PHARMACEUTICALS, INC. (RIGL) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$450,000FY2023 · since FY2016: $546,000 → $450,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $450,000 | -28.2% |
| FY2022 | $627,000 | -50.3% |
| FY2021 | $1.3M | -13.3% |
| FY2020 | $1.5M | +31.6% |
| FY2019 | $1.1M | +574.4% |
| FY2018 | $164,000 | -79.6% |
| FY2017 | $804,000 | +47.3% |
| FY2016 | $546,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice